<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03126513</url>
  </required_header>
  <id_info>
    <org_study_id>R-2017-3601-45</org_study_id>
    <nct_id>NCT03126513</nct_id>
  </id_info>
  <brief_title>Gastric Per Oral Endoscopic Myotomy (G-POEM) in Refractory Gastroparesis</brief_title>
  <acronym>G-POEM</acronym>
  <official_title>Safety and Efficacy of Gastric Per Oral Endoscopic Myotomy (G-POEM) in Patients With Refractory Gastroparesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coordinación de Investigación en Salud, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coordinación de Investigación en Salud, Mexico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Refractory gastroparesis is a disease characterized by a delayed gastric emptying without a
      mechanical obstruction. Actual treatments have a limited efficacy and gastric per-oral
      endoscopic myotomy (G-POEM) is a new treatment that has demonstrated initial promising
      results in these patients. The investigators aims are to evaluate security and efficacy of
      this endoscopic treatment in participants with refractory gastroparesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastroparesis is a chronic, condition characterized by a delayed gastric emptying without a
      mechanical obstruction. This disease is associated with high morbidity and mortality with a
      prevalence up to 4% of population. Patients with this disease have a reduced quality of life.
      The principal etiologies include: post-surgical, diabetes, medications and idiopathic.
      Symptoms include nausea, vomiting, early satiety, bloating and abdominal pain. Diagnosis is
      based on the combination of symptoms and studies as gastroscopy that shows retained food in
      the stomach without a gastric outlet obstruction and confirmed with a gastric emptying
      scintigraphy. Treatments have limited effect in these patients, including medications,
      botulinum toxin injection, surgical gastric electrical stimulation, laparoscopic pyloroplasty
      and stent placement. G-POEM is a new technique based on per-oral endoscopic myotomy treatment
      in achalasia patients, which has been recently proposed for treatment of patients with
      refractory gastroparesis with good initial results. The investigators aim is to evaluate the
      safety and efficacy of this new technique in a group of mexican participants with this
      disease.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This a prospective study that evaluates G-POEM in a group of participants with diagnosis of refractory gastroparesis. Participants are sequentially recruited as diagnosed.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of G-POEM in gastroparesis in percentage of scintigraphic improvement at 4hrs</measure>
    <time_frame>1, 6 and 12 months</time_frame>
    <description>The investigators will compare the percentage of improvement in scintigraphy before and after procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of G-POEM in gastroparesis in percentage of improvement in GCSI questionnaire of symptoms</measure>
    <time_frame>1,6 and 12 months</time_frame>
    <description>The investigators wil compare the percentage of improvement in the GCSI score before and after procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>security of G-POEM in gastroparesis</measure>
    <time_frame>up to 30 days after procedure</time_frame>
    <description>measured as the presence of complications during or after procedure</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Gastroparesis Postoperative</condition>
  <condition>Gastroparesis Due to Diabetes Mellitus</condition>
  <condition>Idiopathic Gastric Stasis</condition>
  <arm_group>
    <arm_group_label>G-POEM in refractory gastroparesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants with refractory gastroparesis will be confirmed by endoscopy, clinical and scintigraphy studies.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>G-POEM</intervention_name>
    <description>After confirmation of refractory gastroparesis, participants will undergo to gastric POEM. Participants will be admitted to hospital 24hrs before procedure and IV antibiotics will be given and then the procedure will be done. Technique consist of 4 steps: First: a submucosa injection of saline solution with methylene blue at 3-4cms from pylorus. Second: a submucosa incision and tunnel creation up to pyloric area. Third: Myotomy of the circular and longitudinal muscular layers of the pylorus and the antrum. Fourth: closure of the mucosal incision with hemoclips. After procedure they will be kept on surveillance and will be followed-up with clinical, endoscopic and scintigraphic studies up to 1 year after procedure.</description>
    <arm_group_label>G-POEM in refractory gastroparesis</arm_group_label>
    <other_name>Gastric per-oral endoscopic myotomy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with refractory gastroparesis based on delayed gastric emptying symptoms:
             Nausea, retching, vomiting, abdominal pain, early satiety, post-prandial fullness,
             bloating.

          -  Refractoriness defines as the presence of symptoms with failure or recurrence after
             other type of treatment.

          -  Any etiology: diabetes, post-surgical, idiopathic

        Exclusion Criteria:

          -  Pregnancy

          -  Portal hypertension

          -  Gastric malignant condition

          -  Active prepyloric ulcer

          -  Mechanical pyloric stenosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oscar V Hernandez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IMSS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oscar V Hernandez Mondragón, MD</last_name>
    <phone>+525556276900</phone>
    <phone_ext>21317-8</phone_ext>
    <email>mondragonmd@yahoo.co.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raquel Palos Cuellar, Fellow</last_name>
    <phone>+525556276900</phone>
    <phone_ext>21317-8</phone_ext>
    <email>palosc5092@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centro Medico Nacional Siglo XXI Hospital de Especialidades</name>
      <address>
        <city>Mexico</city>
        <state>Mexico city</state>
        <zip>06700</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oscar V Hernandez Mondragon, MD</last_name>
      <phone>+525556276900</phone>
      <phone_ext>21317-8</phone_ext>
      <email>mondragonmd@yahoo.co.uk</email>
    </contact>
    <contact_backup>
      <last_name>Raquel Palos Cuellar, MD</last_name>
      <phone>+525556276900</phone>
      <phone_ext>21317-8</phone_ext>
      <email>palosc5092@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <results_reference>
    <citation>Ahuja NK, Clarke JO. Pyloric Therapies for Gastroparesis. Curr Treat Options Gastroenterol. 2017 Mar;15(1):230-240. doi: 10.1007/s11938-017-0124-4. Review.</citation>
    <PMID>28124202</PMID>
  </results_reference>
  <results_reference>
    <citation>Khashab MA, Ngamruengphong S, Carr-Locke D, Bapaye A, Benias PC, Serouya S, Dorwat S, Chaves DM, Artifon E, de Moura EG, Kumbhari V, Chavez YH, Bukhari M, Hajiyeva G, Ismail A, Chen YI, Chung H. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017 Jan;85(1):123-128. doi: 10.1016/j.gie.2016.06.048. Epub 2016 Jun 25.</citation>
    <PMID>27354102</PMID>
  </results_reference>
  <results_reference>
    <citation>Mekaroonkamol P, Li LY, Dacha S, Xu Y, Keilin SD, Willingham FF, Cai Q. Gastric peroral endoscopic pyloromyotomy (G-POEM) as a salvage therapy for refractory gastroparesis: a case series of different subtypes. Neurogastroenterol Motil. 2016 Aug;28(8):1272-7. doi: 10.1111/nmo.12854. Epub 2016 May 15.</citation>
    <PMID>27197717</PMID>
  </results_reference>
  <results_reference>
    <citation>Xue HB, Fan HZ, Meng XM, Cristofaro S, Mekaroonkamol P, Dacha S, Li LY, Fu XL, Zhan SH, Cai Q. Fluoroscopy-guided gastric peroral endoscopic pyloromyotomy (G-POEM): a more reliable and efficient method for treatment of refractory gastroparesis. Surg Endosc. 2017 Nov;31(11):4617-4624. doi: 10.1007/s00464-017-5524-y. Epub 2017 Apr 13.</citation>
    <PMID>28409375</PMID>
  </results_reference>
  <results_reference>
    <citation>Geyl S, Legros R, Charissou A, Mesturoux L, Couquet CY, Carrier P, Brayette A, El-Ouafi Z, Loustaud-Ratti V, Sautereau D, Monteil J, Jacques J. Peroral endoscopic pyloromyotomy accelerates gastric emptying in healthy pigs: proof of concept. Endosc Int Open. 2016 Jul;4(7):E796-9. doi: 10.1055/s-0042-108192. Epub 2016 Jun 29.</citation>
    <PMID>27556100</PMID>
  </results_reference>
  <results_reference>
    <citation>Gonzalez JM, Lestelle V, Benezech A, Cohen J, Vitton V, Grimaud JC, Barthet M. Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video). Gastrointest Endosc. 2017 Jan;85(1):132-139. doi: 10.1016/j.gie.2016.07.050. Epub 2016 Jul 28.</citation>
    <PMID>27478028</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 18, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>G-POEM</keyword>
  <keyword>Safety</keyword>
  <keyword>Efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Gastroparesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

